Fibromyalgia;La fibromyalgie

Revue de Medecine Interne

Volumn 29, Issue 2, 2008, Pages 161-168

  Auquier, L ^a   Bontoux, D ^b   Loo H ^c   Godeau, P ^a   Menkes C J ^a   Paolaggi, J B ^a   Perrot, S ^d  

^a hôpital Jean Bernard ^*  (France)

^b University of Poitiers   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d HÔTEL DIEU   (France)

Author keywords

Antidepressive drugs; Chronic pain; Fatigue; Fibromyalgia; Sleep disturbance; Somatisation

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; CORTICOSTEROID DERIVATIVE; CYCLOBENZAPRINE; DOPAMINE; DULOXETINE; FLUOXETINE; HYPNOTIC AGENT; MILNACIPRAN; MORPHINE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PARACETAMOL PLUS TRAMADOL; PRAMIPEXOLE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE COURSE; EVIDENCE BASED MEDICINE; EXERCISE; FIBROMYALGIA; HUMAN; KNOWLEDGE; MEDICAL SOCIETY; MENTAL DISEASE; NEUROIMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; SHORT SURVEY; SOCIAL ASPECT; TREATMENT PLANNING; UNITED STATES;

FIBROMYALGIA; HUMANS; PROGNOSIS;

EID: 38649118823     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.08.004     Document Type: Short Survey

References (60)

1. Smythe H.A., and Moldofsky H. Two contributions to understanding of the « fibrositis » syndrome. Bull Rheum Dis 28 (1977) 928-931
2. Kahn M.F. Le syndrome polyalgique diffus. Concours Med 110 (1988) 1119-1122
3. Yunus M.B., Masi A.T., Calabro J.J., Miller K.A., and Feigenbaum S.L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11 (1981) 151-171
4. Wolfe F. Development of criteria for the diagnosis of fibrositis. Am J Med 81 suppl 3A (1986) 99-104
5. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33 (1990) 160-172
6. Wolfe F., Ross K., Anderson J., Russel I.J., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
7. Lindell L., Bergman S., and Petersson I.F. Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 18 (2000) 149-153
8. White K.P., Speechley M., Harth M., and Ostbye T. The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London Ontario. J Rheumatol 26 (1999) 1570-1576
9. Gamero Ruiz F., Sanchez G., Abello C., Molina T., and Sanchez-Magro I. Rev Clin Esp 205 (2005) 157-163
10. Yunus M.B. A comprehensive medical evaluation of patients with fibromyalgia syndrome. Rheum Dis Clin North Am 28 (2002) 201-217
11. Friedberg F., and Jason L. Chronic fatigue syndrome and fibromyalgia. Clinical assessment and treatment. J Clin Psychol 57 (2001) 433-455
12. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am 28 (2002) 353-365
13. White K.P., and Thompson J. Fibromyalgia syndrome in Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol 30 (2003) 1835-1840
14. Wolfe F. Pain extent and diagnosis development and validation of the Regional Pain Scale in 12,709 patients with rheumatic diseases. J Rheumatol 30 (2003) 369-378
15. Arnold L.M., Hudson J.L., Keck P.E., Auchenbach M.B., Javaras K.M., and Hess E.V. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67 (2006) 1219-1225
16. Viala A. La depression : des pratiques aux théories. Encéphale 32 (2006) 586-587
17. Cathébras P. Troubles fonctionnels et somatisation (2006), Masson, Paris
18. El-Hage W., Lamy C., Goupille Ph, Gaillard P., and Camus V. Fibromyalgie : une maladie du traumatisme psychique. Presse Med 35 (2006) 1683-1689
19. Weir P.T., Harlan G.A., Nkoy F.L., Jones S.S., Hegmann K.T., Gren L.H., et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 12 (2006) 124-128
20. Wolfe F., and Michaud K. Severe rheumatoid arthritis, worse outcomes, comorbid illness, and sociodemographic disavantage characterize RA patients with fibromyalgia. J Rheumatol 31 (2004) 695-700
21. Akkasilpa S., Goldman D., Magder LS., and Petri M. Number of fibromyalgia tender points is associated with health status in patients with systemic lupus erythematosus. J Rheumatol 32 (2005) 48-50
22. Ostuni P., Botsios C., Sfriso P., Punzi L., Chieco-Bianchi F., Semerano L., et al. Fibromyalgie chez les patients italiens atteints d'un syndrome de Gougerot-Sjögren primitif. Rev Rhum 69 (2002) 56-63
23. Narvaez J., Nolla J.M., and Valverde-Garcia J. Lack of association of fibtomyalgia with hepatitis C virus infection. J Rheumatol 32 (2005) 1118-1121
24. Carette S., and Lefrançois L. Fibrosisis in primary hypothyroidism. J Rheumatol 15 (1988) 1418-1421
25. Pamuk O.N., and Cakir N. The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms. Clin Rheumatol 26 (2007) 55-59
26. Yunus M.B., Inanici F., Aldag J.C., and Mangold R.F. Fibromyalgia in men: comparison of clinical features with women. J Rheumatol 27 (2000) 485-490
27. Masi A.T., White K.P., and Pilcher J.J. Person-centered approach in care, teaching and research in fibromyalgia syndrome: justification from biopsychosocial perspectives in population. Semin Arthritis Rheum 52 (2002) 71-93
28. Mease P.J., Claw D.J., Arnold L.M., Goldenberg D.L., Witter J., Williams D.A., et al. Fibromyalgia syndrome. J Rheumatol 32 (2005) 2270-2272
29. Henriksson C.M., Liedberg G.M., and Gerdle B. Women with fibromyalgia: work and rehabilitation. Disability Rehab 27 (2005) 685-695
30. Burckhardt C.S., Clark S.R., and Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
31. Perrot S., Dumont D., Guillemin F., Pouchot J., and Coste J. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the Fibromyalgia Impact Questionnaire. J Rheumatol 30 (2003) 1054-1059
32. Price D.D., and Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol 32 suppl. 75 (2005) 22-28
33. Offenbaecher M., Bondy B., De Jonge S., Glatzeder K, Kruger M., Schoeps P., et al. Possible association of fibromyalgia with a polymorphism in seroronin transporter gene R region. Arthritis Rheum 42 (1999) 2482-2488
34. Mountz J.M., Bradley L.A., Modell J.G., Alexander R.W., Triana-Alexander M., Aaron L.A., et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38 (1995) 926-938
35. Kwiatek R., Barnden L., Tedman R., Jarrett R., Chew J., Rowe C., et al. Regional cerebral blood flow in fibromyalgia. Arthritis Rheum 43 (2000) 2823-2833
36. Gracely R., Petzke F., Wolf J.M., and Claw D.J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgie. Arthritis Rheum 46 (2002) 1333-1343
37. Adler G.K., and Geenen R. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin North Am 31 (2005) 187-202
38. Bennett R.M., Cook D.M., Clark S.R., Burckhardt C.S., and Campbell S.M. Hypothalamic-pituitary-insulin-like growth factor 1 axis dysfunction in patients with fibromyalgia. J Rheumatol 24 (1997) 1384-1389
39. Perrot S. Des médicaments pour traiter la fibromyalgie ? Revue et analyse de la littérature. Rev Rhum 70 (2003) 340-345
40. Tofferi J.K., Jackson J.L., and O'Malley P.G. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum 51 (2004) 9-13
41. Biasi G., Manca S., Mangagnelli S., and Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharm Res 1 (1998) 13-19
42. Bennett R.M., Schein J., Kosinski M.R., Hewitt D.J., Jordan D.M., and Rosenthal N.R. Impact of fibromyalgia pain on health related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 53 (2005) 519-527
43. Limon J., Paolaggi J.B., and Auquier L. Essai contrôlé de l'amitriptyline sur un groupe de patients atteints d'algies pseudorhumatismales dites « fonctionnelles ». Presse Med 14 (1985) 2107
44. Carette S., McCain G.A., Bell D.A., and Fam A.G. Evaluation of amitriptyline in primary fibrositis. A double blind, placebo-controlled study. Arthritis Rheum 29 (1986) 655-669
45. Wolfe F., Cathey M.A., and Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23 (1994) 255-259
46. Norregaard J., Volkmann H., and Danneskiol-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61 (1995) 445-449
47. O'Malley P.G., Balden E., Tomkins G., Santoro J., Kroenke K., and Jackson J.L. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15 (2000) 659-666
48. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., Ivengar S., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 (2004) 2974-2984
49. Dwight M.M., Arnold L.M., O'Brien H., Metzger R., Monis-Park O., and Keck Jr. P.E. An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics 39 (1998) 14-17
50. Gendreau R.M., Thorn M.D., Gendreau J.F., Kranzler J.D., Ribeiro S., Gracely R.H., et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32 (2005) 1975-1985
51. Crofford L.J., Rowbotham M.C., Mease P.J., Russell I.J., Dworkin R.H., Corbin A.E., et al. Pregabalin for the treatment of fibromyalgia syndrome. Arthritis Rheum 52 (2005) 1264-1273
52. Holman A.J., and Myers R.R. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52 (2005) 2495-2505
53. Sim J., and Adams N. Systematic review of randomized controlled trials of nonpharmacological interventions in fibromyalgia. Clin J Pain 18 (2002) 324-336
54. Morley S. RCTs of psychological treatments for chronic pain: progress and challenges. Pain 121 (2006) 171-172
55. Burckhardt C.S. Multidisciplinary approaches for management of fibromyalgia. Curr Pharm Des 12 (2006) 59-66
56. Goldenberg D.L., Burckhardt C., and Crofford L. Management of fibromyalgia syndrome. JAMA 292 (2004) 2388-2395
57. Cedraschi C., Desmeules J., Rapiti E., Baumgartner E., Cohen P., Finckh A., et al. Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management. Ann Rheum Dis 63 (2004) 290-296
58. Busch AJ. Exercise for treating fibromyalgia syndrome (review). The Cochrane Collaboration. 2006.
59. Harris R.E., Tian X., Williams D.A., Tian T.X., Cupps T.R., Petzke F., et al. Treatment of fibromyalgia with formula acupuncture: investigation of needle placement, needle stimulation, and treatment frequency. J Altern Complement Med 11 (2005) 663-671
60. Martin D.P., Sletten C.D., Williams B.A., and Berger I.H. Improvement in fibromyalgia symptoms with acupuncture: results of a randomized controlled trial. Mayo Clin Proc 81 (2006) 749-757